Local Anesthetics — MCQs

Local Anesthetics Indian Medical PG Practice Questions and MCQs

Question 131: Which of the following conditions makes the nerve membrane more susceptible to the action of local anesthetics?

A. Increased extracellular potassium (Correct Answer)
B. Increased extracellular calcium
C. Increased extracellular sodium
D. Decreased extracellular chloride

Explanation: **Explanation:** The susceptibility of a nerve fiber to local anesthetics (LAs) is significantly influenced by the resting membrane potential and the state of sodium channels. **Why Increased Extracellular Potassium is Correct:** Local anesthetics work by binding to the intracellular portion of voltage-gated sodium channels, primarily in the **activated** or **inactivated** states (state-dependent blockade). When extracellular potassium levels rise (**Hyperkalemia**), the resting membrane potential becomes less negative (depolarized). This partial depolarization shifts more sodium channels from the "resting" state to the "inactivated" state. Since LAs have a higher affinity for inactivated channels, hyperkalemia enhances the local anesthetic blockade. **Why Other Options are Incorrect:** * **Increased Extracellular Calcium:** High calcium levels (**Hypercalcemia**) stabilize the nerve membrane. Calcium ions compete with LAs for binding sites and increase the threshold for excitation, making the nerve *less* susceptible to LAs. * **Increased Extracellular Sodium:** LAs work by competitively inhibiting sodium influx. Increasing the sodium concentration gradient opposes the block, making the nerve *more resistant* to the anesthetic effect. * **Decreased Extracellular Chloride:** Chloride ions primarily influence inhibitory postsynaptic potentials (via GABA receptors) but do not significantly alter the primary mechanism of LA action on axonal sodium channels. **High-Yield Clinical Pearls for NEET-PG:** 1. **State-Dependent Block:** LAs bind more effectively to channels that are frequently opening (active) or are already inactivated. This is also called "use-dependent" or "phasic" block. 2. **Hypokalemia:** Conversely, low potassium hyperpolarizes the membrane, keeping channels in the "resting" state and reducing LA efficacy. 3. **Order of Blockade:** Small myelinated fibers (A-delta) and unmyelinated fibers (C) are blocked before large myelinated fibers (A-alpha). Clinically, the sequence is: **Pain > Temperature > Touch > Pressure > Motor.**

Question 132: A patient with a history of hepatitis one month ago should preferably be given which local anesthetic agent?

A. Lignocaine
B. Bupivacaine
C. Procaine (Correct Answer)
D. Procainamide

Explanation: **Explanation:** The core concept tested here is the **site of metabolism** of local anesthetics (LAs). Local anesthetics are classified into two groups: **Amides** and **Esters**. 1. **Why Procaine is Correct:** Procaine is an **ester-linked** local anesthetic. Esters are primarily metabolized by **pseudocholinesterase (plasma cholinesterase)** in the blood. Since the liver is not the primary site of metabolism for esters, Procaine is the safest choice for a patient with recent hepatitis or compromised liver function. 2. **Why the other options are incorrect:** * **Lignocaine (Lidocaine) & Bupivacaine:** These are **amide-linked** local anesthetics (identified by the "i" before the "-caine"). Amides are metabolized almost exclusively by **hepatic microsomal enzymes** (Cytochrome P450). In a patient with a history of hepatitis, hepatic clearance is reduced, significantly increasing the risk of systemic toxicity (LAST). * **Procainamide:** While it sounds similar to procaine, it is a Class 1A antiarrhythmic agent, not a primary local anesthetic used for regional blocks. **NEET-PG High-Yield Pearls:** * **Mnemonic:** Amides have two "i"s in their name (L**i**doca**i**ne, Bup**i**vaca**i**ne, Pr**i**loca**i**ne, Rop**i**vaca**i**ne), whereas Esters have only one (Proca**i**ne, Chloroproca**i**ne, Coca**i**ne, Tetraca**i**ne). * **Exception:** Cocaine is an ester but is partially metabolized in the liver. * **Prilocaine** is associated with **methemoglobinemia** due to its metabolite, o-toluidine. * **Bupivacaine** is the most cardiotoxic LA; **Levobupivacaine** and **Ropivacaine** are safer alternatives with less cardiotoxicity.

Question 133: Overdosage of a local anesthetic agent would most likely cause which of the following?

A. Hypertension
B. Hypotension (Correct Answer)
C. No change in blood pressure
D. Cardiac arrhythmias

Explanation: **Explanation:** Local anesthetic (LA) toxicity, often referred to as **LAST (Local Anesthetic Systemic Toxicity)**, primarily affects the Central Nervous System and the Cardiovascular System. **Why Hypotension is the Correct Answer:** The primary mechanism of LA action is the blockade of voltage-gated sodium channels. In cases of overdosage, systemic absorption leads to: 1. **Direct Myocardial Depression:** LAs (especially Bupivacaine) inhibit sodium channels in the myocardium, decreasing contractility (negative inotropy). 2. **Peripheral Vasodilation:** LAs cause relaxation of vascular smooth muscle (except Cocaine), leading to a significant drop in systemic vascular resistance. 3. **Conduction Blockade:** They slow the heart rate (negative chronotropy) and cause conduction delays. The combination of decreased cardiac output and peripheral vasodilation results in **profound hypotension**. **Analysis of Incorrect Options:** * **A. Hypertension:** This is generally not seen in LA toxicity. While a transient rise in BP may occur during the initial CNS excitation phase (due to sympathetic discharge), the hallmark of systemic toxicity is cardiovascular collapse and hypotension. * **C. No change in BP:** Systemic levels of LA are potent cardiodepressants; a significant overdose will invariably affect hemodynamics. * **D. Cardiac Arrhythmias:** While arrhythmias (like ventricular tachycardia or bradyarrhythmias) *do* occur, they are usually a manifestation of severe toxicity. **Hypotension** is the more consistent and immediate hemodynamic consequence of the generalized vasodilation and myocardial depression seen in overdosage. **High-Yield NEET-PG Pearls:** * **Order of Toxicity:** CNS symptoms (perioral numbness, metallic taste, seizures) usually precede CVS symptoms. * **Most Cardiotoxic LA:** Bupivacaine (due to slow dissociation from sodium channels—"fast in, slow out" kinetics). * **Antidote:** **Intravenous Lipid Emulsion (20% Intralipid)** is the specific treatment for LAST. * **Cocaine Exception:** Cocaine is the only LA that causes vasoconstriction and hypertension because it inhibits catecholamine reuptake.

Question 134: What is the pKa of lidocaine?

A. 8.1
B. 8.9
C. 7.8 (Correct Answer)
D. 7.6

Explanation: **Explanation:** The **pKa** of a local anesthetic (LA) is the pH at which 50% of the drug exists in the lipid-soluble unionized form and 50% in the water-soluble ionized form. This value is the primary determinant of the **onset of action**. **1. Why 7.8 is Correct:** Lidocaine has a pKa of **7.8**. Since this value is relatively close to the physiological pH (7.4), a larger fraction of the drug remains in the unionized (base) form at the time of injection. This allows for rapid diffusion across the lipid nerve membrane, resulting in a **fast onset of action** (typically 2–5 minutes). **2. Analysis of Incorrect Options:** * **A. 8.1:** This is the pKa of **Bupivacaine** and **Ropivacaine**. Because this is further from physiological pH, more of the drug exists in the ionized form, leading to a slower onset of action. * **B. 8.9:** This is the pKa of **Procaine**. Being highly basic, it has a very slow onset. * **D. 7.6:** This is the pKa of **Mepivacaine**. While Mepivacaine has an even faster onset than lidocaine due to this lower pKa, it is not the value for lidocaine. **3. NEET-PG High-Yield Pearls:** * **Onset of Action:** Inversely proportional to pKa. **Lower pKa = Faster onset.** (Exception: Chloroprocaine, which has a high pKa but is used in high concentrations). * **Infected Tissue:** In acidic environments (e.g., abscesses), the pH drops. This increases the ionized fraction of the LA, preventing it from crossing the nerve membrane, which explains why LAs work poorly in infected tissues. * **Potency:** Determined by **lipid solubility**. * **Duration of Action:** Determined by **protein binding**.

Question 135: It is difficult to obtain local infiltration anesthesia in the presence of inflammation because of which of the following?

A. A decreased pH (Correct Answer)
B. Increased vascularity
C. Edema
D. Pain

Explanation: ### Explanation **1. Why "A decreased pH" is correct:** Local anesthetics (LAs) are **weak bases**. In their commercial preparation, they exist in an equilibrium between a non-ionized (lipid-soluble) form and an ionized (water-soluble) form. Only the **non-ionized form** can cross the lipid-rich neuronal membrane to reach its site of action. According to the Henderson-Hasselbalch equation, in an acidic environment (low pH) caused by inflammation (due to the release of lactic acid and inflammatory mediators), the equilibrium shifts toward the **ionized form**. Since ionized molecules cannot penetrate the nerve sheath, the concentration of the drug reaching the axoplasm is significantly reduced, leading to anesthetic failure. **2. Analysis of Incorrect Options:** * **B. Increased vascularity:** While inflammation causes vasodilation which can lead to faster systemic absorption (shorter duration of action), it is not the primary reason for the *failure to achieve* initial anesthesia. * **C. Edema:** Edema may dilute the anesthetic solution slightly, but it does not chemically prevent the drug from entering the nerve. * **D. Pain:** Pain is the symptom resulting from the failure of anesthesia, not the physiological cause of the failure itself. **3. High-Yield NEET-PG Pearls:** * **Mechanism of Action:** LAs block voltage-gated **sodium (Na+) channels** from the *inside* of the cell. * **pKa Relationship:** The closer the pKa of a local anesthetic is to the tissue pH (7.4), the faster the onset of action (e.g., Lidocaine has a lower pKa than Procaine, hence faster onset). * **Sodium Bicarbonate:** Clinicians sometimes add sodium bicarbonate to LAs to raise the pH, increasing the non-ionized fraction and accelerating the onset of the block. * **Infected Tissues:** Never inject directly into an abscess; the acidic environment ensures the block will be ineffective and may spread the infection.

Question 136: Which of the following local anesthetics is NOT an amide?

A. Lignocaine
B. Procaine (Correct Answer)
C. Mepivacaine
D. Dibucaine

Explanation: Local anesthetics are clinically classified into two main groups based on their chemical linkage: **Amides** and **Esters**. ### 1. Why Procaine is the Correct Answer **Procaine** is an **ester-linked** local anesthetic. Esters are characterized by having a single "i" in their name (e.g., Procaine, Chloroprocaine, Tetracaine, Benzocaine). They are metabolized by plasma pseudocholinesterase and are more likely to cause allergic reactions due to the formation of para-aminobenzoic acid (PABA). ### 2. Why the Other Options are Incorrect Options A, C, and D are all **amide-linked** local anesthetics. A simple mnemonic for NEET-PG is that all amides contain **two "i"s** in their name: * **Lignocaine (Lidocaine):** The most commonly used amide; has a rapid onset and intermediate duration. * **Mepivacaine:** An amide with a pharmacological profile similar to lidocaine but lacks its vasodilator properties. * **Dibucaine:** A potent, long-acting amide. It is clinically significant for the "Dibucaine Number" test used to detect atypical pseudocholinesterase. ### 3. High-Yield Clinical Pearls for NEET-PG * **Metabolism:** Amides are metabolized primarily in the **liver** (by CYP450 enzymes), whereas esters are metabolized in the **plasma** (by pseudocholinesterase). * **Allergy:** True allergic reactions are rare with amides but common with esters (due to PABA). * **Cocaine:** It is the only ester that is a potent vasoconstrictor (all others are vasodilators). * **Prilocaine:** An amide known for causing **methemoglobinemia** at high doses. * **Bupivacaine:** The most cardiotoxic local anesthetic; Intralipid (20% lipid emulsion) is the antidote for toxicity.

Question 137: Bupivacaine toxicity causes which of the following?

A. Renal toxicity
B. Pulmonary toxicity
C. Cardiotoxicity (Correct Answer)
D. None of the above

Explanation: **Explanation:** **Bupivacaine** is a long-acting amide local anesthetic (LA) widely used in regional anesthesia. Its most significant and life-threatening side effect is **Cardiotoxicity**, which occurs due to its high affinity for voltage-gated sodium channels in the myocardium. **Why Cardiotoxicity is the Correct Answer:** Bupivacaine binds more tightly and dissociates much more slowly from cardiac sodium channels compared to other LAs (like Lidocaine). This "slow-in, slow-out" kinetic property leads to a prolonged recovery of the cardiac action potential. Clinically, this manifests as severe ventricular arrhythmias (VT/VF), AV block, and profound myocardial depression. Notably, bupivacaine toxicity often presents with a narrow margin between the dose required for CNS toxicity (seizures) and the dose causing cardiovascular collapse. **Why Other Options are Incorrect:** * **Renal Toxicity:** Local anesthetics are primarily metabolized by the liver (amides) or plasma esterases (esters) and excreted by the kidneys, but they do not cause direct nephrotoxicity. * **Pulmonary Toxicity:** While systemic toxicity can lead to respiratory arrest due to CNS depression or paralysis of respiratory muscles (if used in high spinal blocks), bupivacaine is not directly toxic to lung tissue. **High-Yield Clinical Pearls for NEET-PG:** * **Antidote:** The specific treatment for Local Anesthetic Systemic Toxicity (LAST) is **Intravenous Lipid Emulsion (20% Intralipid)**. It acts as a "lipid sink," sequestering the lipophilic bupivacaine from the cardiac tissue. * **R-Isomer vs. S-Isomer:** Bupivacaine is a racemic mixture. Its S-enantiomers, **Levobupivacaine** and **Ropivacaine**, were developed to provide similar analgesic effects with significantly lower cardiotoxicity. * **Pregnancy:** Bupivacaine cardiotoxicity is enhanced in pregnancy due to increased sensitivity of the myocardium.

Question 138: What is the role of sodium bisulphate in a local anesthetic solution?

A. Reducing agent (Correct Answer)
B. Aesthetic agent
C. Vasoconstrictor
D. Preservative

Explanation: ### Explanation **Correct Option: A (Reducing agent)** Sodium bisulphate (or sodium metabisulphite) is added to local anesthetic (LA) solutions that contain **epinephrine (adrenaline)**. Epinephrine is highly unstable and prone to oxidation, which turns the solution brown and renders it ineffective. Sodium bisulphate acts as an **antioxidant (reducing agent)** by reacting with oxygen before it can oxidize the epinephrine, thereby extending the shelf life and maintaining the potency of the vasoconstrictor. **Analysis of Incorrect Options:** * **B. Aesthetic agent:** This is a distractor; "aesthetic" refers to appearance or beauty and has no pharmacological role in LA solutions. * **C. Vasoconstrictor:** While sodium bisulphate is found in solutions containing vasoconstrictors, it is not the agent itself. Epinephrine and Phenylephrine are the actual vasoconstrictors used to decrease systemic absorption and prolong the block. * **D. Preservative:** While it "preserves" the epinephrine, in pharmacological terms, preservatives (like **Methylparaben**) are specifically added to multi-dose vials to prevent microbial growth. Sodium bisulphate is specifically classified as an antioxidant/reducing agent. **High-Yield Clinical Pearls for NEET-PG:** * **Allergy Alert:** Patients with "sulfite sensitivity" (common in asthmatics) may react to the sodium bisulphate in LA, not the anesthetic drug itself. In such cases, use "plain" LA (without epinephrine). * **pH Changes:** The addition of sodium bisulphate lowers the pH of the solution (makes it more acidic), which can increase the "sting" upon injection and slightly delay the onset of action. * **Hyaluronidase:** Sometimes added to LA to increase the speed of onset and spread (the "spreading factor").

Question 139: Amide type of local anesthetic agents undergo biotransformation primarily in which organ?

A. Kidney
B. Liver (Correct Answer)
C. Plasma
D. Excreted in unaltered form

Explanation: **Explanation:** Local anesthetics (LAs) are chemically classified into two categories based on their intermediate chain: **Amides** and **Esters**. The site of metabolism is the fundamental difference between these two groups. **1. Why Liver is Correct:** Amide-type local anesthetics (e.g., Lidocaine, Bupivacaine, Ropivacaine) undergo complex biotransformation primarily in the **liver** via **microsomal P450 enzymes** (specifically N-dealkylation and hydroxylation). Because their clearance depends on hepatic blood flow and enzyme function, patients with liver failure or congestive heart failure are at a higher risk of systemic toxicity (LAST). **2. Why other options are incorrect:** * **Plasma:** This is the primary site for **Ester-type** local anesthetics (e.g., Procaine, Tetracaine, Benzocaine). They are rapidly hydrolyzed by **pseudocholinesterase** (plasma cholinesterase). * **Kidney:** While the kidneys are the primary route for **excretion** of the metabolites, they are not the primary site of metabolism. * **Excreted in unaltered form:** Only a very small fraction (<5%) of local anesthetics is excreted unchanged in the urine. **High-Yield Clinical Pearls for NEET-PG:** * **Mnemonic:** Amides have two "i"s in their name (L**i**doca**i**ne, Pr**i**loca**i**ne, Bup**i**vaca**i**ne), while Esters have only one (Proca**i**ne, Chloroproca**i**ne). * **Prilocaine Metabolism:** A metabolite of prilocaine (o-toluidine) can cause **methemoglobinemia**, treated with Methylene Blue. * **Rate of Metabolism:** Esters are metabolized much faster than amides, making esters generally less likely to cause systemic toxicity but more likely to cause allergic reactions (due to PABA formation).

Question 140: What is observed in systemic local anesthetic toxicity?

A. Postsynaptic depression leading to convulsions
B. Postconvulsion central nervous system depression (Correct Answer)
C. Generalized convulsions
D. Central nervous system depression

Explanation: ### Explanation **Local Anesthetic Systemic Toxicity (LAST)** occurs due to high plasma concentrations of local anesthetics, primarily affecting the Central Nervous System (CNS) and the Cardiovascular System. **Why Option B is Correct:** The CNS effects of LAST follow a predictable, biphasic progression. Initially, local anesthetics selectively block **inhibitory pathways** (GABAergic neurons) in the cerebral cortex. This "disinhibition" allows excitatory pathways to function unopposed, leading to excitatory symptoms like tremors and **generalized convulsions**. However, as plasma levels continue to rise, the drug eventually blocks **both inhibitory and excitatory pathways**, leading to a state of generalized **post-convulsion CNS depression**. This phase is characterized by respiratory depression, coma, and eventually respiratory arrest. **Analysis of Incorrect Options:** * **Option A:** Convulsions are caused by the blockade of inhibitory pathways (disinhibition), not by postsynaptic depression. * **Option C & D:** While both generalized convulsions and CNS depression occur during toxicity, **Option B** is the most comprehensive answer as it describes the definitive clinical progression and the dangerous end-stage of the toxicity spectrum. **High-Yield Clinical Pearls for NEET-PG:** * **Earliest Sign:** Perioral numbness, metallic taste, and tinnitus. * **Most Cardiotoxic LA:** **Bupivacaine** (due to slow dissociation from cardiac sodium channels—"fast in, slow out" kinetics). * **Treatment of Choice:** **20% Intralipid (Lipid Emulsion Therapy)**. It acts as a "lipid sink," sequestering the lipophilic drug from the plasma. * **Potentiating Factors:** Hypercapnia, acidosis, and hypoxia worsen toxicity by increasing cerebral blood flow and decreasing protein binding.

Practice by Chapter

Chemistry and Mechanism of Action

Practice Questions

Pharmacokinetics of Local Anesthetics

Practice Questions

Amide Local Anesthetics

Practice Questions

Ester Local Anesthetics

Practice Questions

Clinical Uses of Local Anesthetics

Practice Questions

Toxicity of Local Anesthetics

Practice Questions

Management of Local Anesthetic Systemic Toxicity

Practice Questions

Adjuvants to Local Anesthetics

Practice Questions

Maximum Safe Doses

Practice Questions

Local Anesthetics in Special Populations

Practice Questions

Allergic Reactions to Local Anesthetics

Practice Questions

Future Developments in Local Anesthetics

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free